awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q58782275-1CA08FDE-A016-4934-ADA6-18CFFECA75A3
Q58782275-1CA08FDE-A016-4934-ADA6-18CFFECA75A3
BestRank
Statement
http://www.wikidata.org/entity/statement/Q58782275-1CA08FDE-A016-4934-ADA6-18CFFECA75A3
How ibrutinib, a B-cell malignancy drug, became an FDA-approved second-line therapy for steroid-resistant chronic GVHD
P2860
Q58782275-1CA08FDE-A016-4934-ADA6-18CFFECA75A3
BestRank
Statement
http://www.wikidata.org/entity/statement/Q58782275-1CA08FDE-A016-4934-ADA6-18CFFECA75A3
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
48cd40ccd699e64ccccf02a4b522d60d3af03bb8
P2860
Ibrutinib is an irreversible molecular inhibitor of ITK driving a Th1-selective pressure in T lymphocytes